Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.

Journal of behavioral medicine - 1 Oct 2015

Sherman Kerry, Shaw Laura-Kate, Champion Katrina, Caldeira Fernanda, McCaskill Margaret

Abstract excerpt

The effect of disease-specific cognitions on interest in clinic-based and direct-to-consumer (DTC) genetic testing was assessed. Participants (N = 309) responded to an online hypothetical scenario and received genetic testing-related messages that varied by risk probability (25, 50, 75 %) and disease type (Alzheimer's disease vs. Type 2 Diabetes). Post-manipulation interest increased for both testing types, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Diabetes Mellitus, Type 2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Perception

Share to Young Adult

Source

Identifiers

PMID: 25813985
DOI: 10.1007/s10865-015-9630-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.PMID 25813985Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

Public perceptions of presymptomatic testing for Alzheimer disease.Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Genetic Testing and Type 2 Diabetes Risk Awareness.Semantic proximity Read ↗

Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.Semantic proximity Read ↗

Perception of Direct‐To‐Consumer Genetic Testing and Direct‐To‐Consumer Advertising of Genetic Tests among Members of a Large Managed Care OrganizationSemantic proximity Read ↗

Effect of Direct‐to‐Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential ConsumersSemantic proximity Read ↗

Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.Semantic proximity Read ↗

Anxiety delivered direct-to-consumer: are we asking the right questions about the impacts of DTC genetic testing?Semantic proximity Read ↗

Motivations, Perceptions and Impacts of Direct-to-Consumer Genetic Testing Among Users in BrazilSemantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.